Virtus Fund Advisers’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $28K | Buy |
1,340
+46
| +4% | +$960 | 0.09% | 97 |
|
|
2024
Q3 | $25.7K | Hold |
1,294
| – | – | 0.1% | 98 |
|
|
2024
Q2 | $20K | Buy |
1,294
+266
| +26% | +$4.12K | 0.08% | 107 |
|
|
2024
Q1 | $16.4K | Hold |
1,028
| – | – | 0.06% | 111 |
|
|
2023
Q4 | $17.3K | Hold |
1,028
| – | – | 0.11% | 100 |
|
|
2023
Q3 | $12K | Hold |
1,028
| – | – | 0.09% | 98 |
|
|
2023
Q2 | $13.8K | Hold |
1,028
| – | – | 0.1% | 100 |
|
|
2023
Q1 | $17K | Buy |
+1,028
| New | +$17K | 0.12% | 102 |
|